Results 121 to 130 of about 31,171 (226)
(A) Effects of halofantrine and vinblastine on MDA-MB-231 TNBC cell proliferation. IC50 indicates the concentration of drug that induce 50% of inhibition of cell proliferation.
Yeongjun Jang (146006) +9 more
core +1 more source
Liposomes prepared from lipids dipalmitoylphosphatidylcholine (DPPC) and dipalmitoylphosphatidylglycerol (DPPG) with cholesterol were used to investigate the percentage of vinblastine encapsulation and the influence of lipid composition on the retention ...
Demetzos, C. +6 more
core +1 more source
Vinblastine-Induced Posterior Reversible Encephalopathy Syndrome in Pediatric Hodgkin Lymphoma
Posterior reversible encephalopathy syndrome (PRES) is a critical care scenario seen with several etiologies. We report a pediatric case of Hodgkin lymphoma presenting with paraneoplastic features of nephrotic syndrome (NS).
Thippeswamy K. M. Siddartha +2 more
core +1 more source
Yuangang Zu, Yu Zhang, Xiuhua Zhao, Qi Zhang, Yang Liu, Ru JiangKey Laboratory of Forest Plant Ecology, Northeast Forestry University, Ministry of Education, Harbin, Heilongjiang, ChinaAbstract: Response surface methodology (RSM) was used to optimize the
Xiuhua Zhao +3 more
core
Giant cell formation: the way to cell death or cell survival?
Horbay Rostyslav, Stoika Rostyslav
doaj +1 more source
The interest of application of liquid membrane (pertraction) processes for recovery of medicinal compounds from dilute ammoniacal leach solutions is demonstrated.
Adil A. Al-Hemiri +2 more
doaj
Efficacy of celecoxib and methotrexate-vinblastine regimen in desmoid-type fibromatosis: A retrospective cohort study. [PDF]
Kawano M +4 more
europepmc +1 more source
Mebendazole Shows Antiproliferative and Antimigratory Effects in Paediatric Low-Grade Glioma Models. [PDF]
Ferraro C +6 more
europepmc +1 more source
Abstracts of 14th International Symposium on Hodgkin Lymphoma
HemaSphere, Volume 10, Issue S2, October 2026.
wiley +1 more source
Risk factors for chemotherapy-induced dysgeusia in patients receiving dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin therapy: a retrospective observational study. [PDF]
Tanaka T +10 more
europepmc +1 more source

